The global medical devices reimbursement market size is expected to reach around US$ 859.8 billion by 2030 from US$ 427.26 billion in 2021 and is expected to grow at an impressive double-digit rate of 8.1% from 2021 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global medical devices reimbursement market for the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2020 is considered as the base year.
The medical devices reimbursement is a payment made to a healthcare provider by a private insurer for expenses incurred while using medical devices. A private and government health insurance will usually pay the patient’s hospital expenses and the use of a medical equipment. The majority of a person’s healthcare reimbursement is covered by the government or a health insurance company, either totally or partially. The medical devices reimbursement has evolved into a critical foundation for ensuring patient’s access to advanced diagnostic and other medical technologies. The reimbursement amount is determined as a payment for specific medical instruments used or as a payment for the complete surgical procedure involving the use of surgical equipment or devices.
We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1506
Why should you invest in this report?
If you are aiming to enter the global medical devices reimbursement market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for medical devices reimbursement are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global medical devices reimbursement market include:
- UnitedHealth Group
- Allianz
- Nippon Life Insurance
- Aviva
- WellCare Health Plans
- Aetna
- BNP Paribas
- Cigna
- Humana
- CVS Health
Market Segmentation:
By Payer
- Public
- Private
By Healthcare Setting
- Hospitals
- Outpatient Facilities
- Others
Regional Analysis:
The geographical analysis of the global medical devices reimbursement market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global medical devices reimbursement Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global medical devices reimbursement market in 2030?
- What is the expected CAGR for the medical devices reimbursement market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global medical devices reimbursement market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Devices Reimbursement Market
5.1. COVID-19 Landscape: Medical Devices Reimbursement Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Devices Reimbursement Market, By Payer
8.1. Medical Devices Reimbursement Market, by Payer Type, 2021-2030
8.1.1. Public
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Private
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Medical Devices Reimbursement Market, By Healthcare Setting
9.1. Medical Devices Reimbursement Market, by Healthcare Setting, 2021-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Outpatient Facilities
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Medical Devices Reimbursement Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Payer (2019-2030)
10.1.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Payer (2019-2030)
10.1.3.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Payer (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Payer (2019-2030)
10.2.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Payer (2019-2030)
10.2.3.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Payer (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Payer (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Payer (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Payer (2019-2030)
10.3.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Payer (2019-2030)
10.3.3.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Payer (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Payer (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Payer (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Payer (2019-2030)
10.4.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Payer (2019-2030)
10.4.3.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Payer (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Payer (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Payer (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Payer (2019-2030)
10.5.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Payer (2019-2030)
10.5.3.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Payer (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Healthcare Setting (2019-2030)
Chapter 11. Company Profiles
11.1. UnitedHealth Group
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Allianz
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Nippon Life Insurance
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Aviva
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. WellCare Health Plans
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Aetna
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. BNP Paribas
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Cigna
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Humana
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. CVS Health
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1506
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
0 Comments